Literature DB >> 16241960

Role of angiotensin-converting enzyme insertion/deletion and plasminogen activator inhibitor-1 4G/5G gene polymorphisms in retinal vein occlusion.

D Mattes, M Weger, W Renner, L Cichocki, A Haas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16241960     DOI： 10.1111/j.1538-7836.2005.01591.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  Genetic Background of a Recurrent Unusual Combined Form of Retinal Vein Occlusion: A Case Report.

Authors:  Kajo Bucan; Ivna Plestina Borjan; Ivona Bucan; Martina Paradzik Simunovic; Ivan Borjan
Journal:  Case Rep Ophthalmol       Date:  2018-04-12

2.  Protective effect of paraoxonase 1 gene variant L55M in retinal vein occlusion.

Authors:  Huseyin Ortak; Erkan Söğüt; Omer Ateş; Unal Erkorkmaz; Ismail Benli; Ali Akbas; Selim Demir; Hüseyin Ozyurt
Journal:  Mol Vis       Date:  2013-02-25       Impact factor: 2.367

3.  Plasminogen activator inhibitor-1 4G/5G gene polymorphism and primary open-angle glaucoma.

Authors:  Georg Mossböck; Martin Weger; Christoph Faschinger; Otto Schmut; Wilfried Renner
Journal:  Mol Vis       Date:  2008-07-04       Impact factor: 2.367

4.  Relationship between angiotensin I-converting enzyme insertion/deletion gene polymorphism and retinal vein occlusion.

Authors:  Işıl Kutluturk; Ali Karagöz; Tahir Bezgin; Vecih Oduncu; Ali Elveran; Cem Doğan; Ahmet Elbay; Cevat Kirma; Yusuf Ozertürk
Journal:  Thromb J       Date:  2014-08-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.